Pathogen inactivation: Making decisions about new technologies - Preliminary report of a consensus conference

Vox Sanguinis

Volumn 93, Issue 2, 2007, Pages 179-182

  Klein, H G ^a   Anderson, D ^b   Bernardi, M J ^c   Cable, R ^d   Carey, W ^e   Hoch, J S ^f   Robitaille, N ^g   Sivilotti, M L A ^h   Smaill, F ⁱ  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^c CENTRE FOR INTERDISCIPLINARY RESEARCH IN REHABILITATION OF GREATER MONTREAL   (Canada)

^d AMERICAN RED CROSS BLOOD SERVICES   (United States)

^e St Michael's Hospital ^*

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF MONTREAL   (Canada)

^h QUEEN S UNIVERSITY   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

Author keywords

Blood transfusion; Pathogen reduction

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; DECISION MAKING; DISEASE TRANSMISSION; ERYTHROCYTE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MATHEMATICAL MODEL; PATHOGENESIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RISK; TECHNOLOGY; THROMBOCYTE; VASCULARIZATION;

EID: 34547747894     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.00937.x     Document Type: Article

References (9)

1. Burnouf T, Radosevich M : Reducing the risk of infection from plasma products: specific preventative strategies. Transfus Med 2002 14 : 94 110
2. Klein HG : Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005 257 : 224 237
3. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC : Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007 47 : 316 325
4. Yomtovian YA, Palavecino EL, Dysktra AH, Downes KA, Morrissey AM, Bajaksouzian S, Pokorny MA, Lazarus HM, Jacobs MR : Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion 2006 46 : 719 730
5. Ramírez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M : Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007 47 : 421 429
6. Dzik WH, Corwin H, Goodnough LT, Higgins M, Kaplan H, Murphy M, Ness P, Shulman IA, Yomtovian R : Patient safety and blood transfusion: new solutions. Transfus Med Rev 2003 17 : 169 180
7. Stoto MA : The precautionary principle and emerging biologic risks: lessons from human immunodeficiency virus in blood products. Semin Hematol 2006 43 : S10 S12
8. Gold M, Siegel J, Russell L, Weinstein M : Cost-Effectiveness in Health and Medicine. New York, Oxford University Press, 1996
9. Mauskopf JA, Paul JE, Grant DM, Stergachis A : The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 1998 13 : 277 288